Travere Therapeutics, Inc.
TVTX
33 insider filings · Latest: May 19, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | May 19 4:05 PM | Timothy CoughlinDirector | Sale | 3,250 | $43.49 | $141.3K | 52,250(D) | View → |
| May 5, 2026 | May 6 8:00 PM | Roy D. BaynesDirector | Sale | 4,500 | $46.65 | $209.9K | 37,500(D) | View → |
| May 4, 2026 | May 6 8:00 PM | Meckler Jeffrey ADirector | Sale | 8,000 | $45.00 | $360.0K | 87,500(D) | View → |
| May 6, 2026 | May 6 8:00 PM | William E. RoteChief Research Officer | Sale | 2,763 | $43.95 | $121.4K | 115,474(D) | View → |
| May 6, 2026 | May 6 8:00 PM | Elizabeth E ReedChief Legal Officer and GC | Sale | 2,076 | $43.95 | $91.2K | 105,211(D) | View → |
| May 5, 2026 | May 6 8:00 PM | Elizabeth E ReedChief Legal Officer and GC | Sale | 2,174 | $46.65 | $101.4K | 107,287(D) | View → |
| May 4, 2026 | May 6 8:00 PM | Elizabeth E ReedChief Legal Officer and GC | Sale | 20,000 | $45.00 | $900.0K | 105,211(D) | View → |
| May 6, 2026 | May 6 8:00 PM | Jula InrigCHIEF MEDICAL OFFICER | Sale | 311 | $43.95 | $13.7K | 113,238(D) | View → |
| May 5, 2026 | May 6 8:00 PM | Jula InrigCHIEF MEDICAL OFFICER | Sale | 2,174 | $46.65 | $101.4K | 113,549(D) | View → |
| May 4, 2026 | May 6 8:00 PM | Jula InrigCHIEF MEDICAL OFFICER | Sale | 20,000 | $45.00 | $900.0K | 111,473(D) | View → |
| May 5, 2026 | May 6 8:00 PM | Peter HeermaCHIEF COMMERCIAL OFFICER | Sale | 2,174 | $46.65 | $101.4K | 140,684(D) | View → |
| May 6, 2026 | May 6 8:00 PM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 22,500 | $43.95 | $988.9K | 432,886(D) | View → |
| May 6, 2026 | May 6 8:00 PM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Sale | 310 | $43.95 | $13.6K | 118,658(D) | View → |
| May 5, 2026 | May 6 8:00 PM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Sale | 2,181 | $46.65 | $101.7K | 118,968(D) | View → |
| May 1, 2026 | May 4 4:27 PM | Roy D. BaynesDirector | Sale | 9,750 | $44.22 | $431.1K | 37,500(D) | View → |
| Apr 22, 2026 | Apr 23 4:05 PM | William E. RoteChief Research Officer | Sale | 9,100 | $39.09 | $355.7K | 113,987(D) | View → |
| Apr 14, 2026 | Apr 16 4:05 PM | LYONS GARY ADirector | Sale | 8,000 | $41.07 | $328.6K | 57,500(D) | View → |
| Apr 14, 2026 | Apr 16 4:05 PM | Roy D. BaynesDirector | Sale | 32,750 | $41.29 | $1.4M | 37,500(D) | View → |
| Apr 14, 2026 | Apr 16 4:05 PM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Sale | 21,977 | $41.07 | $902.6K | 42,353(D) | View → |
| Apr 14, 2026 | Apr 15 9:49 PM | Peter HeermaCHIEF COMMERCIAL OFFICER | Sale | 7,215 | $41.93 | $302.5K | 138,608(D) | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | May 21 5:00 PM | Brinkley Ruth WilliamsDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 5:00 PM | Ron SquarerDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 5:00 PM | Sandra PooleDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 5:00 PM | John A OrwinDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 5:00 PM | Meckler Jeffrey ADirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 5:00 PM | LYONS GARY ADirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 5:00 PM | Timothy CoughlinDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 5:00 PM | Suzanne Louise BruhnDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 19, 2026 | May 21 5:00 PM | Roy D. BaynesDirector | Grant/Award | 12,000 | $42.26 | 12,000(D) | View → |
| May 5, 2026 | May 6 8:00 PM | Roy D. BaynesDirector | Option Exercise | 4,500 | $18.27 | 0(D) | View → |
| May 4, 2026 | May 6 8:00 PM | Meckler Jeffrey ADirector | Option Exercise | 8,000 | $16.33 | 0(D) | View → |
| May 4, 2026 | May 6 8:00 PM | William E. RoteChief Research Officer | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 6 8:00 PM | William E. RoteChief Research Officer | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 6 8:00 PM | Elizabeth E ReedChief Legal Officer and GC | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 6 8:00 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 24,250 | $17.96 | 4,250(D) | View → |
| May 4, 2026 | May 6 8:00 PM | Jula InrigCHIEF MEDICAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 6 8:00 PM | Jula InrigCHIEF MEDICAL OFFICER | Option Exercise | 24,250 | $22.40 | 4,250(D) | View → |
| May 4, 2026 | May 6 8:00 PM | Peter HeermaCHIEF COMMERCIAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 6 8:00 PM | Peter HeermaCHIEF COMMERCIAL OFFICER | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 4, 2026 | May 6 8:00 PM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 45,000 | — | 45,000(D) | View → |
Page 1 of 2
Next →